Recent Posts

1. 

   CMX is a train wreck

   Sleep with Chris Boner

   Bristol-Myers Squibb

   anonymous

   May 20, 2024 at 12:13 PM

2. 

   Stupid iPhones and laptops

   Fuck off.

   Novartis

   anonymous

   May 20, 2024 at 12:02 PM

3. 

   Market Caps

   What happened? No Celgene magic left to rally the BMS share price? (In case you have not noticed, BMS is 'underperforming'.)

   Bristol-Myers Squibb

   anonymous

   May 20, 2024 at 12:01 PM

4. 

   Dermtech

   Ray had a personal grudge against a manager and drove the #1 rep and him away. Paid his Dermira people more than established managers and reps, changed the bonus structure to give his goons the advantage, kept pay for play for his goon out west,...

   Laboratory/Diagnostic Sales General Discussion

   anonymous

   May 20, 2024 at 11:58 AM

5. 

   Elevar

   We hope this message finds you well. We appreciate the time and effort you invested in applying and interviewing for the Oncology Account Manager role at Elevar Therapeutics. Due to unforeseen changes in our operational plans following a recent...

   Biotech Startups

   anonymous

   May 20, 2024 at 11:57 AM

6. 

   2019:BMS buys celgene for 74b. 2024 BMS market cap: 89b

   Wrong company...some people on this board have an interest, but do not work at BMS... Son

   Bristol-Myers Squibb

   anonymous

   May 20, 2024 at 11:50 AM

7. 

   AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle

   via Pfizer, through its Wyeth unit, is entitled to receive $107.5 million in damages from AstraZeneca after a Delaware federal jury on Friday found that the British-Swedish pharma’s cancer drug Tagrisso (osimertinib) violated patent protections....

   Pharma/Biotech Companies - In the News

   cafead

   May 20, 2024 at 11:42 AM

8. + Show More